Skip to main content
. 2021 Apr 3;901:174082. doi: 10.1016/j.ejphar.2021.174082

Fig. 9.

Fig. 9

(A) The ten docked potential inhibitors against SARS-CoV-2 PLPRO from PubChem COVID-19 clinical trial compounds, (B) Top 10 potential inhibitors bind to PLPRO protein, (C) The surface protein with ligand bound to the pocket.